日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Primary Analysis of a Phase II Study of Atezolizumab plus Bevacizumab for TACE-Unsuitable Patients with Tumor Burden beyond Up-To-Seven Criteria in Intermediate-Stage Hepatocellular Carcinoma: REPLACEMENT Study

一项针对不适合接受经导管动脉化疗栓塞术(TACE)且肿瘤负荷超过“Up-To-7”标准的中晚期肝细胞癌患者的阿特珠单抗联合贝伐珠单抗治疗的II期研究的主要分析:REPLACEMENT研究

Kudo, Masatoshi; Ueshima, Kazuomi; Tsuchiya, Kaoru; Yamashita, Tatsuya; Shimose, Shigeo; Numata, Kazushi; Kodama, Yuzo; Itoh, Shinji; Tanaka, Yasuhito; Kuroda, Hidekatsu; Aikata, Hiroshi; Hiraoka, Atsushi; Moriguchi, Michihisa; Tateishi, Ryosuke; Ogasawara, Sadahisa; Yamamoto, Kouji; Ikeda, Masafumi

Multidisciplinary Treatment With Hepatic Arterial Infusion Chemotherapy, Radiotherapy, and Immunotherapy for Advanced Hepatocellular Carcinoma With Major Vascular Invasion: Prospective Registry Protocol

采用肝动脉灌注化疗、放疗和免疫疗法对伴有主要血管侵犯的晚期肝细胞癌进行多学科治疗:前瞻性注册研究方案

Doi, Yoshiko; Aikata, Hiroshi; Kosaka, Yumi; Nakahara, Takashi; Kodama, Michiyo; Hieda, Masashi; Hashimoto, Masakazu; Nakahara, Hideki; Takahashi, Ippei; Kakizawa, Hideaki; Mori, Nami; Tsuji, Keiji; Imano, Nobuki; Murakami, Yuji; Sueda, Saki; Kawaoka, Tomokazu; Tsuge, Masataka; Oka, Shiro

Targeting the liver clock improves fibrosis by restoring TGF-β signaling

靶向肝脏生物钟可通过恢复TGF-β信号通路改善纤维化

Crouchet, Emilie; Dachraoui, Mayssa; Jühling, Frank; Roehlen, Natascha; Oudot, Marine A; Durand, Sarah C; Ponsolles, Clara; Gadenne, Cloé; Meiss-Heydmann, Laura; Moehlin, Julien; Martin, Romain; Brignon, Nicolas; Del Zompo, Fabio; Teraoka, Yuji; Aikata, Hiroshi; Abe-Chayama, Hiromi; Chayama, Kazuaki; Saviano, Antonio; Heide, Danijela; Onea, Mihaela; Geyer, Lucas; Wolf, Thibaut; Felli, Emanuele; Pessaux, Patrick; Heikenwälder, Mathias; Chambon, Pierre; Schuster, Catherine; Lupberger, Joachim; Mukherji, Atish; Baumert, Thomas F

First-Line Lenvatinib plus Pembrolizumab for Hepatocellular Carcinoma: Post hoc Analysis of Japanese Patients from the Phase 3 LEAP-002 Trial

一线使用乐伐替尼联合帕博利珠单抗治疗肝细胞癌:LEAP-002 III期试验中日本患者的事后分析

Kudo, Masatoshi; Ikeda, Masafumi; Aikata, Hiroshi; Numata, Kazushi; Marusawa, Hiroyuki; Hosaka, Tetsuya; Kato, Naoya; Kurosaki, Masayuki; Morimoto, Manabu; Yamashita, Tatsuya; Koga, Hironori; Masaki, Tsutomu; Yatsuzuka, Naoyoshi; Suzuki, Masato; Nagao, Satoshi; Kaneko, Shuichi; Kumada, Hiromitsu

Atezolizumab plus Bevacizumab with Transcatheter Arterial Chemoembolization (Sandwich Strategy) versus Atezolizumab plus Bevacizumab Alone in Hepatocellular Carcinoma: A Multicenter Retrospective Study

阿特珠单抗联合贝伐珠单抗经导管动脉化疗栓塞术(三明治策略)与阿特珠单抗单药联合贝伐珠单抗治疗肝细胞癌的疗效比较:一项多中心回顾性研究

Hashimoto, Ko; Kawaoka, Tomokazu; Emori, Tomoaki; Tanaka, Aiko; Shirane, Yuki; Miura, Ryoichi; Fujii, Yasutoshi; Nakahara, Hikaru; Yamaoka, Kenji; Uchikawa, Shinsuke; Fujino, Hatsue; Ono, Atsushi; Murakami, Eisuke; Miki, Daiki; Hayes, C Nelson; Hiramatsu, Akira; Amioka, Kei; Nonaka, Michihiro; Aisaka, Yasuyuki; Morio, Kei; Moriya, Takashi; Teraoka, Yuji; Kono, Hirotaka; Suehiro, Yosuke; Masaki, Keiichi; Ohya, Kazuki; Takaki, Shintaro; Mori, Nami; Tsuji, Keiji; Kosaka, Yumi; Nakahara, Takashi; Aikata, Hiroshi; Tsuge, Masataka; Oka, Shiro

A patient-derived HCC spheroid system to model the tumor microenvironment and treatment response

利用患者来源的肝细胞癌球体系统模拟肿瘤微环境和治疗反应

Crouchet, Emilie; Almeida, Nuno; Durand, Sarah C; Parnot, Marie; Oudot, Marine A; Giannone, Fabio; Gadenne, Cloé; Roehlen, Natascha; Saviano, Antonio; Felli, Emanuele; Pessaux, Patrick; Duong, Hong Tuan; Ohdan, Hideki; Aikata, Hiroshi; Chayama, Kazuaki; Baumert, Thomas F; Schuster, Catherine

Atezolizumab Plus Bevacizumab for TACE-Unsuitable Intermediate-Stage HCC Beyond Up-To-7 Criteria: Final Analysis of REPLACEMENT

阿特珠单抗联合贝伐珠单抗治疗不适合经TACE治疗且超出Up-To-7标准的中晚期肝细胞癌:REPLACEMENT研究的最终分析

Ueshima, Kazuomi; Tsuchiya, Kaoru; Yamashita, Tatsuya; Shimose, Shigeo; Numata, Kazushi; Kodama, Yuzo; Itoh, Shinji; Tanaka, Yasuhito; Kuroda, Hidekatsu; Ohkawa, Kazuyoshi; Kuzuya, Teiji; Ikeda, Masafumi; Kooka, Youhei; Aikata, Hiroshi; Hiraoka, Atsushi; Moriguchi, Michihisa; Tateishi, Ryosuke; Ogasawara, Sadahisa; Yamamoto, Kouji; Kudo, Masatoshi

Impact of viral eradication by direct-acting antivirals on clinical outcomes after curative treatment for hepatitis C virus-associated hepatocellular carcinoma

直接抗病毒药物清除病毒对丙型肝炎病毒相关肝细胞癌根治性治疗后临床结局的影响

Nagaoki, Yuko; Yamaoka, Kenji; Fujii, Yasutoshi; Uchikawa, Shinsuke; Fujino, Hatsue; Ono, Atsushi; Murakami, Eisuke; Kawaoka, Tomokazu; Miki, Daiki; Aikata, Hiroshi; Hayes, Clair Nelson; Tsuge, Masataka; Oka, Shiro

Multicenter Phase II Trial of Lenvatinib plus Hepatic Intra-Arterial Infusion Chemotherapy with Cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD

LEOPARD 研究是一项多中心 II 期临床试验,旨在评估乐伐替尼联合顺铂肝动脉灌注化疗治疗晚期肝细胞癌的疗效。

Ikeda, Masafumi; Yamashita, Tatsuya; Ogasawara, Sadahisa; Kudo, Masatoshi; Inaba, Yoshitaka; Morimoto, Manabu; Tsuchiya, Kaoru; Shimizu, Satoshi; Kojima, Yasushi; Hiraoka, Atsushi; Nouso, Kazuhiro; Aikata, Hiroshi; Numata, Kazushi; Sato, Tosiya; Okusaka, Takuji; Furuse, Junji

A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L Trial

一项针对不可切除的中晚期肝细胞癌患者的经动脉化疗栓塞治疗联合乐伐替尼治疗的II期前瞻性多中心单臂试验:TACTICS-L试验

Kudo, Masatoshi; Ueshima, Kazuomi; Saeki, Issei; Ishikawa, Toru; Inaba, Yoshitaka; Morimoto, Naoki; Aikata, Hiroshi; Tanabe, Nobukazu; Wada, Yoshiyuki; Kondo, Yasuteru; Tsuda, Masahiro; Nakao, Kazuhiko; Ito, Takanori; Hosaka, Tetsuya; Kawamura, Yusuke; Kuzuya, Teiji; Nojiri, Shunsuke; Ogawa, Chikara; Koga, Hironori; Hino, Keisuke; Ikeda, Masafumi; Moriguchi, Michihisa; Hisai, Takashi; Yoshimura, Kenichi; Furuse, Junji; Arai, Yasuaki